Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis

NCT02505113 · clinicaltrials.gov ↗

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Portal Vein, Cavernous Transformation Of

Interventions

DRUG: Montelukast

Sponsor

Sun Yat-sen University